Peer Review reports
From: Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
Original Submission | ||
---|---|---|
14 Aug 2022 | Submitted | Original manuscript |
25 Aug 2022 | Reviewed | Reviewer Report - Takao Takeshima |
29 Aug 2022 | Reviewed | Reviewer Report |
11 Sep 2022 | Author responded | Author comments - Giorgio Lambru |
Resubmission - Version 2 | ||
11 Sep 2022 | Submitted | Manuscript version 2 |
Publishing | ||
12 Sep 2022 | Editorially accepted | |
4 Nov 2022 | Article published | 10.1186/s10194-022-01507-8 |
You can find further information about peer review here.